RVTY vs. THC: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at RVTY and THC, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
Symbol | RVTY | THC |
---|---|---|
Company Name | Revvity, Inc. | Tenet Healthcare Corporation |
Country | United States | United States |
GICS Sector | Health Care | Health Care |
GICS Industry | Life Sciences Tools & Services | Health Care Providers & Services |
Market Capitalization | 10.65 billion USD | 17.85 billion USD |
Exchange | NYSE | NYSE |
Listing Date | February 21, 1973 | March 17, 1980 |
Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of RVTY and THC by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
Symbol | RVTY | THC |
---|---|---|
5-Day Price Return | 3.74% | 3.26% |
13-Week Price Return | -9.38% | 15.36% |
26-Week Price Return | -18.36% | 52.62% |
52-Week Price Return | -30.47% | 24.40% |
Month-to-Date Return | -2.73% | 10.15% |
Year-to-Date Return | -21.47% | 60.85% |
10-Day Avg. Volume | 1.32M | 1.17M |
3-Month Avg. Volume | 1.25M | 1.43M |
3-Month Volatility | 40.14% | 35.98% |
Beta | 1.01 | 1.54 |
Profitability
Return on Equity (TTM)
RVTY
3.71%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
RVTY’s Return on Equity of 3.71% is in the lower quartile for the Life Sciences Tools & Services industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.
THC
37.25%
Health Care Providers & Services Industry
- Max
- 24.86%
- Q3
- 15.79%
- Median
- 8.56%
- Q1
- 5.75%
- Min
- -1.64%
THC’s Return on Equity of 37.25% is exceptionally high, placing it well beyond the typical range for the Health Care Providers & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
Net Profit Margin (TTM)
RVTY
10.19%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
RVTY’s Net Profit Margin of 10.19% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
THC
7.17%
Health Care Providers & Services Industry
- Max
- 11.56%
- Q3
- 5.45%
- Median
- 2.83%
- Q1
- 1.13%
- Min
- -1.71%
A Net Profit Margin of 7.17% places THC in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
RVTY
13.57%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
RVTY’s Operating Profit Margin of 13.57% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
THC
17.77%
Health Care Providers & Services Industry
- Max
- 19.08%
- Q3
- 9.66%
- Median
- 4.77%
- Q1
- 2.46%
- Min
- -0.83%
An Operating Profit Margin of 17.77% places THC in the upper quartile for the Health Care Providers & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
Symbol | RVTY | THC |
---|---|---|
Return on Equity (TTM) | 3.71% | 37.25% |
Return on Assets (TTM) | 2.29% | 5.11% |
Net Profit Margin (TTM) | 10.19% | 7.17% |
Operating Profit Margin (TTM) | 13.57% | 17.77% |
Gross Profit Margin (TTM) | 55.93% | 82.36% |
Financial Strength
Current Ratio (MRQ)
RVTY
3.33
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
RVTY’s Current Ratio of 3.33 is in the upper quartile for the Life Sciences Tools & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
THC
1.71
Health Care Providers & Services Industry
- Max
- 2.00
- Q3
- 1.51
- Median
- 1.29
- Q1
- 0.92
- Min
- 0.14
THC’s Current Ratio of 1.71 is in the upper quartile for the Health Care Providers & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
Debt-to-Equity Ratio (MRQ)
RVTY
0.43
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
RVTY’s Debt-to-Equity Ratio of 0.43 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
THC
3.51
Health Care Providers & Services Industry
- Max
- 2.29
- Q3
- 1.24
- Median
- 0.74
- Q1
- 0.50
- Min
- 0.00
With a Debt-to-Equity Ratio of 3.51, THC operates with exceptionally high leverage compared to the Health Care Providers & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
Interest Coverage Ratio (TTM)
RVTY
15.30
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
RVTY’s Interest Coverage Ratio of 15.30 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
THC
10.27
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.50
- Median
- 4.52
- Q1
- 2.12
- Min
- -4.44
THC’s Interest Coverage Ratio of 10.27 is in the upper quartile for the Health Care Providers & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
Financial Strength at a Glance
Symbol | RVTY | THC |
---|---|---|
Current Ratio (MRQ) | 3.33 | 1.71 |
Quick Ratio (MRQ) | 2.75 | 1.54 |
Debt-to-Equity Ratio (MRQ) | 0.43 | 3.51 |
Interest Coverage Ratio (TTM) | 15.30 | 10.27 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
RVTY
0.32%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
RVTY’s Dividend Yield of 0.32% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
THC
0.00%
Health Care Providers & Services Industry
- Max
- 5.93%
- Q3
- 2.59%
- Median
- 1.35%
- Q1
- 0.00%
- Min
- 0.00%
THC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
RVTY
11.88%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
RVTY’s Dividend Payout Ratio of 11.88% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
THC
0.00%
Health Care Providers & Services Industry
- Max
- 185.33%
- Q3
- 74.82%
- Median
- 36.00%
- Q1
- 0.00%
- Min
- 0.00%
THC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
Symbol | RVTY | THC |
---|---|---|
Dividend Yield (TTM) | 0.32% | 0.00% |
Dividend Payout Ratio (TTM) | 11.88% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
RVTY
36.78
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
RVTY’s P/E Ratio of 36.78 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
THC
11.92
Health Care Providers & Services Industry
- Max
- 40.02
- Q3
- 29.75
- Median
- 21.09
- Q1
- 14.18
- Min
- 7.05
In the lower quartile for the Health Care Providers & Services industry, THC’s P/E Ratio of 11.92 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
Price-to-Sales Ratio (TTM)
RVTY
3.75
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
RVTY’s P/S Ratio of 3.75 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
THC
0.86
Health Care Providers & Services Industry
- Max
- 3.15
- Q3
- 1.87
- Median
- 0.74
- Q1
- 0.27
- Min
- 0.09
THC’s P/S Ratio of 0.86 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
RVTY
1.51
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
RVTY’s P/B Ratio of 1.51 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
THC
4.36
Health Care Providers & Services Industry
- Max
- 7.33
- Q3
- 4.45
- Median
- 2.52
- Q1
- 1.15
- Min
- 0.66
THC’s P/B Ratio of 4.36 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
Symbol | RVTY | THC |
---|---|---|
Price-to-Earnings Ratio (TTM) | 36.78 | 11.92 |
Price-to-Sales Ratio (TTM) | 3.75 | 0.86 |
Price-to-Book Ratio (MRQ) | 1.51 | 4.36 |
Price-to-Free Cash Flow Ratio (TTM) | 20.85 | 7.99 |